VSee Health, Inc. (VSEED) Stock Price & Analysis
VSee Health, Inc. (VSEED) closed at USD 1.89 on Thursday, October 15, 2026, down 0.53% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 1.9; the Oct 15, 2026 session ranged USD 1.65–1.9 on volume of 5,365 shares. Market capitalization is $1.52M, with a 52-week range of USD 0.01–3.5 (PNK). Source: Nexqual, retrieved October 16, 2026 at 07:25 UTC.
Also available as compact Markdown for AI agents: nexqual.com/VSEED.md
Key facts (VSEED)
- Analysts: None.
- Total return with dividends: 1Y +264.9% vs S&P 500 +18.1%; 5Y -80.9% vs S&P 500 +85.1%.
Analysts (VSEED)
Consensus None.
Total return (dividends reinvested) (VSEED)
| 1Y (from 2025-10-16) | 5Y (from 2021-12-27) | |
|---|---|---|
| Total return | +264.9% | -80.9% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +266.5% | -29.1% |
| Volatility (annualized) | 486.1% | 246.6% |
| Max drawdown | -99.1% (Oct 2025→Sep 2026) | -99.9% (May 2024→Sep 2026) |
Key Statistics (as of October 16, 2026 at 07:25 UTC)
| Price | USD 1.89 |
|---|---|
| Change | ▼ 0.53% (down) |
| Previous Close | USD 1.9 |
| Open | USD 1.65 |
| Day Range | USD 1.65 – 1.9 |
| 52-Week Range | USD 0.01 – 3.5 |
| Volume | 5,365 shares |
| Market Cap | $1.52M |
| Exchange | PNK |
Technical Analysis (VSEED)
Nexqual's technical model rates VSEED "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of October 16, 2026 at 07:25 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 63.03 (neutral) |
| vs SMA50 | Above (USD 0.64) |
| MACD | 0.42 (positive) |
Analyst Ratings (VSEED)
Wall Street analysts rate VSEED "None", per Nexqual as of October 16, 2026 at 07:25 UTC.
| Consensus Rating | None |
|---|
Earnings (VSEED)
Source: Nexqual, October 16, 2026 at 07:25 UTC.
Financials & Fundamentals (VSEED)
| Total Revenue | $15.81M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +48.00% |
| Gross Margin | +43.43% |
| Operating Margin | -172.70% |
| Profit Margin | -62.59% |
| ROE | -1455.88% |
| Debt / Equity | 0.27 |
| Current Ratio | 0.4 |
| Total Cash | $454,151 |
| Total Debt | $2.02M |
Source: Nexqual, October 16, 2026 at 07:25 UTC.
Financial Health Score (VSEED)
Nexqual rates VSee Health, Inc.'s overall financial health "Mixed" across five dimensions, as of October 16, 2026 at 07:25 UTC.
| Growth | Strong — Revenue +48% YoY (latest Q) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Solid — $454K cash vs $2M debt |
| Cash Flow | Weak — Operating cash flow -$6M (TTM) |
| Efficiency | Critical — ROE -1456%, ROA -38.8% |
Ownership (VSEED)
| Insider Ownership | +14.60% |
|---|---|
| Institutional Ownership | +13.04% |
| Shares Outstanding | 806,078 |
| Float | 554,003 |
| Short % of Float | +15.44% |
Source: Nexqual, October 16, 2026 at 07:25 UTC.
Leadership (VSEED)
VSee Health, Inc. is led by Imoigele P. Aisiku (age 53), President, CEO & Chairman, per Nexqual as of October 16, 2026 at 07:25 UTC.
| President, CEO & Chairman | Imoigele P. Aisiku (age 53) |
|---|---|
| Senior VP, CFO & Secretary | Jerry Leonard C.P.A. (age 57) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CARL | Carlsmed, Inc. | USD 13.95 | ▼ 3.59% |
| CTEV | Claritev Corporation | USD 23.86 | ▲ 0.59% |
| NRC | NRC Health | USD 21.11 | ▲ 4.66% |
| EVH | Evolent Health, Inc | USD 4.87 | ▲ 5.87% |
| WEAV | Weave Communications, Inc. | USD 7.39 | ▲ 0.27% |
| SOPH | SOPHiA GENETICS SA | USD 7.29 | ▲ 2.82% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 07:25 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt